File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Camrelizumab for nasopharyngeal carcinoma: a new hope?

TitleCamrelizumab for nasopharyngeal carcinoma: a new hope?
Authors
Kwong, DLW
Issue Date2018
PublisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/j.lancetoncol
Citation
The Lancet Oncology, 2018, v. 19 n. 10, p. 1266-1267 How to Cite?
DOI: http://dx.doi.org/10.1016/S1470-2045(18)30579-5
Persistent Identifierhttp://hdl.handle.net/10722/274917
ISSN
1470-2045
2023 Impact Factor: 41.6
2023 SCImago Journal Rankings: 12.179
ISI Accession Number ID
WOS:000446052800035

 

DC FieldValueLanguage
dc.contributor.authorKwong, DLW-
dc.date.accessioned2019-09-10T02:31:34Z-
dc.date.available2019-09-10T02:31:34Z-
dc.date.issued2018-
dc.identifier.citationThe Lancet Oncology, 2018, v. 19 n. 10, p. 1266-1267-
dc.identifier.issn1470-2045-
dc.identifier.urihttp://hdl.handle.net/10722/274917-
dc.languageeng-
dc.publisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/j.lancetoncol-
dc.relation.ispartofThe Lancet Oncology-
dc.titleCamrelizumab for nasopharyngeal carcinoma: a new hope?-
dc.typeArticle-
dc.identifier.emailKwong, DLW: dlwkwong@hku.hk-
dc.identifier.authorityKwong, DLW=rp00414-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S1470-2045(18)30579-5-
dc.identifier.pmid30213451-
dc.identifier.scopuseid_2-s2.0-85054777856-
dc.identifier.hkuros303233-
dc.identifier.volume19-
dc.identifier.issue10-
dc.identifier.spage1266-
dc.identifier.epage1267-
dc.identifier.isiWOS:000446052800035-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1470-2045-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats